Bayer launches critical care analyser worldwide
This article was originally published in Clinica
Executive Summary
Bayer Diagnostics is launching the Rapidpoint 400, its first near-patient blood gas and electrolyte analyser for intensive care, operating theatre or casualty units. The device can report results on any or all analytes within 60 seconds, making it, the makers claim, the fastest response of any point-of-care blood gas system. It also has intuitive sample management that can give warning of short samples, blood clots or gas bubbles.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.